Funding for this research was provided by:
the Project of the National Natural Science Funding of China (81472207)
the Special Fund for Research in the Public Interest from the National Health and Family Planning Commission of PRC (201402031)
Key Lab System Project of Guangdong Science and Technology Department–Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2012A061400006/2017B030314120)
Research Funds from the Guangzhou Science and Technology Bureau (201607010391 and 2016B020237006)
Text and Data Mining valid from 2018-11-26
Received: 19 March 2018
Accepted: 12 November 2018
First Online: 26 November 2018
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of the Guangdong General Hospital and all patients provided written informed consents.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.